Antitumor Activity of Polymorphonuclear Leukocytes Activated by a β-1,3-D-Glucan
スポンサーリンク
概要
- 論文の詳細を見る
The antitumor activity of mouse polymorphonuclear leukocyte (PMN) treated with a β-1,3-D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 (TAK-N) and its carboxymethylated derivative (CM-TAK) was investigated in vitro and in vivo. ICR mouse PMN showed strong cytotoxicity against sarcoma 180 cells and inhibition of the growth of the tumor cells in vitro in the presence of TAK-N but not in the presence of CM-TAK. Since the cytotoxicity induced by TAK-N was almost completely inhibited by catalase, it seems to be mediated by H_2O_2 production by PMN. On the other hand, TAK-N induced no cytotoxicity in macrophages and neither did CM-TAK in PMN or in macrophage. Intraperitoneal injection of TAK-N into ICR mice induced a large number of PMN and macrophages in the peritoneal cavity. The peritoneal exudate PMN which were harvested at 10 to 72 h after TAK-N injection showed cytotoxicity against sarcoma 180 cells, but the peritoneal exudate macrophages did not. Treatment of sarcoma 180 ascites tumor-bearing ICR mice with TAK-N at a dose of 100 mg/kg prolonged significantly the survival time over that of the control. These results indicate that TAK-N induces PMN cytotoxicity against sarcoma 180 cells not only in vitro but also in vivo. The antitumor effect of TAK-N on sarcoma 180 ascites tumor seems to be derived from PMN stimulated with TAK-N.
- 公益社団法人日本薬学会の論文
著者
-
Nitta Kazuo
Chemotherapy Division Chiba Cancer Center Research Institute:chemotherapy Division National Cancer C
-
Baba Hiroyasu
Chemotherapy Division Chiba Cancer Center Research Institute:chemotherapy Division National Cancer C
-
Kunimoto Takehiko
Chemotherapy Division Chiba Cancer Center Research Institute:chemotherapy Division National Cancer C
-
KASAI Shunji
Chemotherapy Division, Chiba Cancer Center Research Institute
-
FUJIMOTO Shuichi
Chemotherapy Division, Chiba Cancer Center Research Institute
-
Fujimoto Shuichi
Chemotherapy Division Chiba Cancer Center Research Institute:chemotherapy Division National Cancer C
-
Kasai Shunji
Chemotherapy Division Chiba Cancer Center Research Institute:chemotherapy Division National Cancer C
関連論文
- ANTITUMOR ACTIVITY OF A NEW CAMPTOTHECIN DERIVATIVE, SN-22,AGAINST VARIOUS MURINE TUMORS
- Antitumor Activity of Polymorphonuclear Leukocytes Activated by a β-1,3-D-Glucan